0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Tumor Suppressor Par-4 - Role in Cancer and Other Diseases (Hardcover, 1st ed. 2021) Loot Price: R4,412
Discovery Miles 44 120
Tumor Suppressor Par-4 - Role in Cancer and Other Diseases (Hardcover, 1st ed. 2021): Vivek M. Rangnekar

Tumor Suppressor Par-4 - Role in Cancer and Other Diseases (Hardcover, 1st ed. 2021)

Vivek M. Rangnekar

 (sign in to rate)
Loot Price R4,412 Discovery Miles 44 120 | Repayment Terms: R413 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Par-4 is a naturally occurring tumor suppressor. Studies have indicated that overexpression of Par-4 selectively induces apoptosis in cancer cells while leaving normal, health, cells unaffected. Mechanisms contributing to this cancer-selective action of Par-4 have been associated with PKA activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. On the other hand, endogenous Par-4 sensitizes cells to the action of a broad range of apoptotic inducers acting via the extrinsic and intrinsic pathways. A number of binding partners of Par-4 have been identified and shown to regulate Par-4 function in cancer and other diseases, such as Alzheimer's and major depression. Recent studies have recognized a number of natural products, dietary supplements, synthetic molecules and FDA-approved drugs that induce the secretion of Par-4 protein to cause apoptosis in primary or metastatic tumors, one of which is in clinical trials. More than 50 different laboratories worldwide are involved in Par-4 based research of this unique protein that has progressed from the bench to clinical trials. This second, companion volume will provide a comprehensive overview of Par-4's role in cancer and other diseases. Chapters are written by leading researchers, and will be useful for a broad audience across the scientific community, particularly students and trainees, who are the next generation of scientists and clinicians to participate in new studies and discoveries on Par-4.

General

Imprint: Springer Nature Switzerland AG
Country of origin: Switzerland
Release date: December 2021
First published: 2021
Editors: Vivek M. Rangnekar
Dimensions: 279 x 210mm (L x W)
Format: Hardcover
Pages: 331
Edition: 1st ed. 2021
ISBN-13: 978-3-03-080557-9
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-03-080557-3
Barcode: 9783030805579

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners